These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3294196)

  • 1. Adenocarcinoma in situ of the cervix. Clinicopathologic observations of 11 cases.
    Tobón H; Dave H
    Int J Gynecol Pathol; 1988; 7(2):139-51. PubMed ID: 3294196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The suitable treatment for adenocarcinoma in situ of uterine cervix: a report of four cases.
    Liu YC; Chen RJ; Chang DY; Huang SC; Chow SN
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Oct; 58(4):294-8. PubMed ID: 8994337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
    McCluggage WG; Shah R; Connolly LE; McBride HA
    Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endocervical adenocarcinoma in situ. A histological entity to know].
    Fignon A; Mayelo V; Wurst C; Magnin G; Tariel D; Descamps P; Renjard L; Body G; Lansac J
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(4):369-73. PubMed ID: 7650312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can adenocarcinoma in situ of the uterine cervix be predicted before cervical conization?
    Kietpeerakool C; Srisomboon J; Prompittayarat W; Kanjanavaha P; Peuwsai R; Dheerakul C
    Asian Pac J Cancer Prev; 2006; 7(4):522-4. PubMed ID: 17250421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-situ and microinvasive adenocarcinoma of the uterine cervix. A clinical, cytologic and histologic study of 14 cases.
    Qizilbash AH
    Am J Clin Pathol; 1975 Aug; 64(2):155-70. PubMed ID: 1155380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
    Poynor EA; Barakat RR; Hoskins WJ
    Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunohistochemical analysis of 26 cases.
    Gilks CB; Young RH; Aguirre P; DeLellis RA; Scully RE
    Am J Surg Pathol; 1989 Sep; 13(9):717-29. PubMed ID: 2764221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
    Denehy TR; Gregori CA; Breen JL
    Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretory adenocarcinoma of the endometrium.
    Tobon H; Watkins GJ
    Int J Gynecol Pathol; 1985; 4(4):328-35. PubMed ID: 4086159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe cervical glandular cell lesions and severe cervical combined lesions: predictive value of the papanicolaou smear.
    van Aspert-van Erp AJ; Smedts FM; Vooijs GP
    Cancer; 2004 Aug; 102(4):210-7. PubMed ID: 15368312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical carcinoid of the uterine cervix accompanying adenocarcinoma in situ.
    Ling C; Shen Y
    J Clin Pathol; 2018 Nov; 71(11):1030. PubMed ID: 30154130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical localization of carcinoembryonic antigen in microglandular hyperplasia and adenocarcinoma of the endocervix.
    Speers WC; Picaso LG; Silverberg SG
    Am J Clin Pathol; 1983 Jan; 79(1):105-7. PubMed ID: 6336881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
    Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
    Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lobular endocervical glandular hyperplasia, not otherwise specified: a clinicopathologic analysis of thirteen cases of a distinctive pseudoneoplastic lesion and comparison with fourteen cases of adenoma malignum.
    Nucci MR; Clement PB; Young RH
    Am J Surg Pathol; 1999 Aug; 23(8):886-91. PubMed ID: 10435557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenocarcinoma in situ of the cervix: management and outcome.
    Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
    Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease.
    Im DD; Duska LR; Rosenshein NB
    Gynecol Oncol; 1995 Nov; 59(2):179-82. PubMed ID: 7590468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An adenocarcinoma in situ of the uterine cervix that developed into invasive adenocarcinoma after 5 years.
    Kashimura M; Shinohara M; Oikawa K; Hamasaki K; Sato H
    Gynecol Oncol; 1990 Jan; 36(1):128-33. PubMed ID: 2295444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenoid basal epitheliomas of the uterine cervix: a reevaluation of distinctive cervical basaloid lesions currently classified as adenoid basal carcinoma and adenoid basal hyperplasia.
    Brainard JA; Hart WR
    Am J Surg Pathol; 1998 Aug; 22(8):965-75. PubMed ID: 9706976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenocarcinoma of the cervix in Jewish women: a clinicopathologic study of seven cases.
    Czernobilsky B; Rotenstreich L; Lancet M
    Isr J Med Sci; 1975 Apr; 11(4):367-72. PubMed ID: 1140955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.